Hamlin Discusses Practice-Changing Data in Lymphoma – OncLive
OncLive |
Hamlin Discusses Practice-Changing Data in Lymphoma
OncLive CAR T-cell therapy is another big story in the large cell lymphoma space that was reported across all the different products that are out there. We had previously seen that CAR T cells can be active in relapsed large cell lymphoma and that response … |
